| abstract |
The present invention relates to certain compounds of formula (1), or pharmaceutically acceptable salts or solvates thereof, methods of making such compounds, pharmaceutical compositions comprising such compounds and vanilloid receptors (VR1) of such compounds and compositions Use for the treatment of disorders (eg, pain, migraine, neuropathy, ischemia, neurodegeneration, stroke, multiple sclerosis, asthma, inflammatory disease). <Formula 1> Wherein R 1 , R 2 , P, P ', n, p, q, r and s are as defined in the specification. |